Diffuse large B-cell lymphoma

PheWeb

HLP_C3_DLBCL

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Cancer registry: Topography ICD-O-3 C42|C77

Cancer registry: Morphology ICD-O-3 9680

Cancer registry: Behaviour codes 3

3911

Check pre-conditions, main-only, mode, ICD version None

361

Check minimum number of events None

361

Include endpoints None

361

HLP_C3_DLBCL

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Diffuse large B-cell lymphoma based on the number of shared cases.

Broader endpoints:

None

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	-	-	-
Unadjusted prevalence (%)	-	-	-
Mean age at first event (years)	-	-	-

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: HLP_C3_DLBCL – Diffuse large B-cell lymphoma
GWS hits:

Survival analyses between endpoints

↥

Plot

before Diffuse large B-cell lymphoma
after Diffuse large B-cell lymphoma

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Diffuse large B-cell lymphoma

↥